Caribou Biosciences, Inc. (CRBU) DCF Valuation
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Caribou Biosciences, Inc. (CRBU) Bundle
Looking to evaluate the intrinsic value of Caribou Biosciences, Inc.? Our (CRBU) DCF Calculator integrates real-world data with extensive customization options, allowing you to adjust forecasts and enhance your investment decisions.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.8 | 12.4 | 9.6 | 13.9 | 34.5 | 53.6 | 83.4 | 129.6 | 201.5 | 313.4 |
| Revenue Growth, % | 0 | 113.56 | -22.35 | 44.31 | 148.91 | 55.49 | 55.49 | 55.49 | 55.49 | 55.49 |
| EBITDA | -30.2 | -35.2 | -66.0 | -104.8 | -112.5 | -53.6 | -83.4 | -129.6 | -201.5 | -313.4 |
| EBITDA, % | -521.99 | -284.82 | -687.59 | -756.46 | -326.4 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | .8 | .9 | 1.0 | 3.6 | 3.5 | 7.2 | 11.2 | 17.4 | 27.0 | 42.0 |
| Depreciation, % | 12.98 | 7.28 | 10.25 | 26.29 | 10.22 | 13.4 | 13.4 | 13.4 | 13.4 | 13.4 |
| EBIT | -31.0 | -36.1 | -67.0 | -108.4 | -116.1 | -53.6 | -83.4 | -129.6 | -201.5 | -313.4 |
| EBIT, % | -534.97 | -292.1 | -697.84 | -782.74 | -336.63 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 49.5 | 16.0 | 413.5 | 317.0 | 328.8 | 53.6 | 83.4 | 129.6 | 201.5 | 313.4 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 4.0 | 5.2 | 8.1 | 4.7 | 3.9 | 25.7 | 40.0 | 62.2 | 96.8 | 150.4 |
| Account Receivables, % | 68.8 | 41.74 | 84.64 | 33.67 | 11.19 | 48.01 | 48.01 | 48.01 | 48.01 | 48.01 |
| Inventories | 3.2 | 2.4 | -31.1 | -62.6 | .0 | -13.4 | -20.9 | -32.5 | -50.5 | -78.6 |
| Inventories, % | 54.98 | 19.68 | -324.14 | -451.74 | 0 | -25.07 | -25.07 | -25.07 | -25.07 | -25.07 |
| Accounts Payable | 2.5 | 2.6 | 4.0 | 1.1 | 3.1 | 13.3 | 20.6 | 32.1 | 49.9 | 77.6 |
| Accounts Payable, % | 43.83 | 21.04 | 41.57 | 8.27 | 9.05 | 24.75 | 24.75 | 24.75 | 24.75 | 24.75 |
| Capital Expenditure | -.9 | -1.3 | -3.1 | -7.1 | -11.6 | -15.3 | -23.8 | -37.1 | -57.7 | -89.6 |
| Capital Expenditure, % | -15.27 | -10.64 | -32.52 | -50.93 | -33.68 | -28.61 | -28.61 | -28.61 | -28.61 | -28.61 |
| Tax Rate, % | -0.18944 | -0.18944 | -0.18944 | -0.18944 | -0.18944 | -0.18944 | -0.18944 | -0.18944 | -0.18944 | -0.18944 |
| EBITAT | -23.4 | -34.3 | -67.3 | -108.5 | -116.3 | -50.5 | -78.5 | -122.0 | -189.7 | -294.9 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -28.2 | -35.1 | -37.5 | -79.8 | -184.2 | -56.9 | -90.6 | -140.9 | -219.0 | -340.6 |
| WACC, % | 13.01 | 13.17 | 13.21 | 13.21 | 13.21 | 13.16 | 13.16 | 13.16 | 13.16 | 13.16 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -535.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -347 | |||||||||
| Terminal Value | -3,113 | |||||||||
| Present Terminal Value | -1,678 | |||||||||
| Enterprise Value | -2,213 | |||||||||
| Net Debt | -24 | |||||||||
| Equity Value | -2,189 | |||||||||
| Diluted Shares Outstanding, MM | 74 | |||||||||
| Equity Value Per Share | -29.66 |
What You Will Get
- Real Caribou Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Caribou Biosciences, Inc. (CRBU).
- Full Customization: Adjust all critical parameters (yellow cells) such as WACC, growth %, and tax rates to fit your analysis.
- Instant Valuation Updates: Automatic recalculations to assess the impact of changes on Caribou’s fair value.
- Versatile Excel Template: Designed for quick edits, scenario testing, and comprehensive projections.
- Time-Saving and Accurate: Avoid building models from scratch while ensuring precision and flexibility in your analyses.
Key Features
- 🔍 Real-Life CRBU Financials: Pre-filled historical and projected data for Caribou Biosciences, Inc.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Caribou’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Caribou’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- 1. Access the Model: Download and open the Excel file containing Caribou Biosciences, Inc. (CRBU) data.
- 2. Adjust Key Inputs: Modify critical parameters such as growth projections, discount rates, and investment costs.
- 3. Analyze Results in Real-Time: The financial model automatically computes intrinsic value and net present value (NPV).
- 4. Explore Different Scenarios: Evaluate various forecasts to assess diverse valuation possibilities.
- 5. Present with Assurance: Deliver expert valuation findings to back your strategic decisions.
Why Choose This Calculator for Caribou Biosciences, Inc. (CRBU)?
- Comprehensive Tool: Integrates DCF, WACC, and financial ratio analyses tailored for biotech companies.
- Customizable Inputs: Modify highlighted cells to explore different financial scenarios.
- Detailed Insights: Automatically computes Caribou's intrinsic value and Net Present Value.
- Preloaded Data: Historical and projected data provide reliable foundations for analysis.
- Professional Quality: Perfect for biotech analysts, investors, and business strategists.
Who Should Use This Product?
- Biotechnology Students: Explore gene editing techniques and apply them using real-world case studies.
- Researchers: Integrate advanced CRISPR models into your studies or publications.
- Investors: Evaluate your investment strategies and analyze market trends for Caribou Biosciences, Inc. (CRBU).
- Analysts: Enhance your analysis with a comprehensive, customizable biotech valuation model.
- Entrepreneurs: Understand how innovative biotech companies like Caribou are evaluated in the market.
What the Caribou Biosciences Template Contains
- Comprehensive DCF Model: Editable template featuring in-depth valuation calculations.
- Real-World Data: Caribou Biosciences’ historical and projected financials preloaded for analysis.
- Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Charts and tables providing clear, actionable results.